Nicolas Gazeau | Authors


Unmet Needs for Managing CRS and ICANS Due to CAR T-Cell Therapy

September 01, 2022

Nicolas Gazeau, MS, discusses next steps and unmet needs following a positive retrospective study of anakinra for the management of neurotoxicity and cytokine release syndrome in patients who received chimeric antigen receptor T-cell therapy.